These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10731780)

  • 1. The role of nuclear medicine in the management of Graves' disease.
    Freitas JE
    Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
    Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
    Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
    Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
    N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
    Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?
    Freitas JE; Swanson DP; Gross MD; Sisson JC
    J Nucl Med; 1979 Aug; 20(8):847-50. PubMed ID: 583469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
    McCullagh EP; Jelden GL; Rodriguez-Antunez A
    Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
    Gómez N; Gómez JM; Orti A; Gavaldà L; Villabona C; Leyes P; Soler J
    J Nucl Med; 1995 Sep; 36(9):1539-42. PubMed ID: 7658207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant].
    Prinsen AK; Jansen J; Bakker WH; Wildschut HI
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2845-8. PubMed ID: 17319213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children.
    Nebesio TD; Siddiqui AR; Pescovitz OH; Eugster EA
    J Pediatr; 2002 Jul; 141(1):99-103. PubMed ID: 12091858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.